+55.4%
CVS vs AKAM
+1.2%
+54.2%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AKAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -3.3% | +3.2% | +0.1% |
| 7D | -2.0% | +0.6% | -2.6% | -2.0% |
| 30D | +1.9% | -8.2% | +10.1% | +2.5% |
| 3M | -2.2% | -17.6% | +15.4% | -1.0% |
| 6M | +26.7% | +2.5% | +24.2% | +25.3% |
| YTD | +22.9% | +22.8% | +0.1% | +18.6% |
| 1Y | +32.9% | +39.6% | -6.7% | +26.1% |
| All | +55.4% | +1.2% | +54.2% | +50.2% |
Cumulative growth
Daily Returns
Daily percentage return beside AKAM.
Daily Out/Under-Performance
Portfolio return minus AKAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AKAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AKAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling